TW201033359A - Alga strain rich in DHA and application of the same - Google Patents

Alga strain rich in DHA and application of the same Download PDF

Info

Publication number
TW201033359A
TW201033359A TW98107877A TW98107877A TW201033359A TW 201033359 A TW201033359 A TW 201033359A TW 98107877 A TW98107877 A TW 98107877A TW 98107877 A TW98107877 A TW 98107877A TW 201033359 A TW201033359 A TW 201033359A
Authority
TW
Taiwan
Prior art keywords
dha
algae
strain
product
rich
Prior art date
Application number
TW98107877A
Other languages
Chinese (zh)
Other versions
TWI372181B (en
Inventor
Yi-Min Chen
Huey-Lang Yang
Chung-Kuang Lu
Original Assignee
Univ Nat Cheng Kung
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Nat Cheng Kung filed Critical Univ Nat Cheng Kung
Priority to TW098107877A priority Critical patent/TWI372181B/en
Publication of TW201033359A publication Critical patent/TW201033359A/en
Application granted granted Critical
Publication of TWI372181B publication Critical patent/TWI372181B/en

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

The present invention relates to an alga strain rich in DHA and application of the same. The alga of the present invention is easy in production, rich in DHA and DHA is easily purified. The products manufactured from this alga containing DHA with high quality which can be used as human healthy foods and pharmaceutics, additives of aquatic and livestock product, and fish meal.

Description

201033359 * 六、發明說明: ' 【發明所屬之技術領域】 本發明係關於—種含高品質DHA之藻株,更進一步 地’本發明係關於一種脂肪酸組成簡單而易於純化DHa之 藻株。 【先前技術】 ❿ 二十一碳六烯酸(docosahexaenoic acid, DHA),含有 6 個 雙鍵的多元不飽和脂肪酸,屬於必需脂肪酸,為大腦與神 L組織中細胞膜的主要成分。DHA已知具有促進腦部及視 網膜發育,以及預防中樞神、經及心血管疾病的功能。目前 許夕市售健康食品標榜含有DHA,強調具有預防或改善憂 鬱症、老年癡呆症以及心血管疾病方面的功效,此外, 亦可作為孕婦及幼兒的健康補給品,標榜可促進嬰、幼兒 腦部發育。對於現今所有的先進國家幾乎都面臨老年化及 少子化的問題,優良的DHA產品恰好能因應這些問題,進 ❿ 而創造無限的商機。 目前市面上有許多多元不飽和脂肪酸(含DHA)的產品來 自於魚油’多取自大型魚’故又俗稱為深海魚油。由於人 類及大部份動物皆不能以代謝方法自行生產DHA,必須從 外界攝取來補充,然而利用魚油提供DHA可能有以下缺 點,包括DHA含量不穩定、魚油成份複雜,提煉DHA的 成本較高、可能含重金屬及多氯聯苯等有毒物質,容易造 成胎兒畸形,或是影響嬰幼兒的發育;此外魚油屬葷食屬 性’不被素食者接受,以及有明顯腥味。 此外’在水產飼料及畜產飼料中需添加足量的DHA,以 利養殖物的發育與成長,同時增強其對疾病之抵抗力。由 3 201033359 於目前水產及畜產養殖的規模逐漸增加,過去其所倚賴的 魚源DHA早已供不應求。藻源DHA正好提供一個可靠的 來源。目前也有利用一般藻種來生產DHA,然而也遭遇到 一些困難’例如DHA產能較低,量產成本較高,以及藻種 所含脂肪酸組成較為複雜,不容易進一步提煉出高純度的 DHA。 & 目前市面上已有利用Grypf/iecodim'um eo/mii &201033359 * VI. Description of the invention: 'Technical field to which the invention pertains>> The present invention relates to a strain of algae containing high-quality DHA, and further to the present invention relates to a strain of algae which is simple in fatty acid composition and easy to purify DHa. [Prior Art] docosahexaenoic acid (DHA), a polyunsaturated fatty acid containing six double bonds, is an essential fatty acid and is a major component of the cell membrane in brain and god L tissues. DHA is known to have functions that promote brain and retina development, as well as prevent central nervous system, menstrual disease, and cardiovascular disease. At present, the health foods on the market in Xuxi are advertised as containing DHA, which emphasizes the prevention or improvement of depression, Alzheimer's disease and cardiovascular diseases. In addition, it can also be used as a health supplement for pregnant women and young children. Department development. For all advanced countries today, almost all of them are faced with the problem of aging and declining. The excellent DHA products can meet these problems and create unlimited business opportunities. At present, there are many products of polyunsaturated fatty acids (including DHA) on the market. The fish oil is often taken from large fishes, so it is also known as deep sea fish oil. Since humans and most animals cannot produce DHA by metabolic methods, they must be ingested from the outside. However, the use of fish oil to provide DHA may have the following disadvantages, including unstable DHA content, complex fish oil composition, and high cost of refining DHA. May contain heavy metals and polychlorinated biphenyls and other toxic substances, which may cause fetal malformation, or affect the development of infants and young children; in addition, fish oil is a foraging property that is not accepted by vegetarians and has a distinct astringency. In addition, a sufficient amount of DHA should be added to aquatic feed and livestock feed to promote the development and growth of the culture while enhancing its resistance to disease. From 3 201033359, the current scale of aquaculture and livestock farming has gradually increased, and the DHA of fish source that it relied on in the past has already been in short supply. The algae source DHA provides a reliable source. At present, there are also some algae species used to produce DHA, but some difficulties have also been encountered. For example, DHA has low productivity, high mass production cost, and the fatty acid composition of algae species is complicated, and it is not easy to further extract high-purity DHA. & Grypf/iecodim'um eo/mii &

Schizochytrium sp.的藻楂 ±^ΌΉΑ,其中 Schizochytrium Jt 品 的DHA含量約為乾藻重的18-22%,其優點是價格便宜, 缺點在於不谷易獲得尚純度DHA;而產品 的DHA含量則約為15-20%,其優點在於容易精鍊出高純 度的DHA,然而DHA含量較低、不容易培養,因此量產成 本高’同時因為〇少/?认eco出m’ww之藻粉有濃郁的刺鼻味, 因此必須經過一些食品加工的處理後才能販賣,造成其成 本的飆漲。 ^ 因此,開發一種高產能、純化容易的DHA的產源將有 助於DHA商品的開發,且可以更低廉的價格提供更高品質 ❿ 的DHA商品,供民眾購買利用。 【發明内容】 有鑑於昔知技術的缺失,本發明之目的在開發一種高產 能、純化容易的DHA產源,以利降低DHA商品之成本與 售價,有助於商品之推廣。 ' 有鑑於此’本發明提供一種用於生產DHA之 如屬屬藥株,特別是如 藻株,目前業已將一藻株寄存於食品工業發展研 究所’該藻株寄存編號係為BCRC980009。 換5之’本發明也包含一種將办屬藻株 201033359 用於生產DHA之用途’特別是將也肋·〇c知的_ • 藻株用於生產DHA,目前業已將一藻株寄存於食 品工業發展研究所’該藻株寄存編號係為BCRC98〇〇〇9。 本电明發現則述也屬藻株富含dha.,可 用於加工製成人用健康食品及保健醫藥、水產或畜產品添 加劑以及幼魚飼料,因此,本發明也包含一種藻株製品, 其係將申請專利範圍第1項所述之藻株乾燥或萃取製得之 DHA半成品或純化物。 利用本發明之藻株製得之藻油相較於魚油具有包含下 列的優點:DHA含量較高、品質穩定、成分單純,容易進 一步精鍊成高純度的OHA、不含重金屬及多氯聯苯等有毒 成份、素食者可食、以及沒有魚腥味等。 此外,相較於其他藻類,利用本發明之藻株來量產類似 產品具有下列之優勢:沒有刺鼻的味道、DHA的含量較高, 以及該藻株為台灣本土性藻種,在台灣生產時無外來種的 問題。 φ 【實施方式】 本發明於研發期間,曾針對台灣沿海區域進行微生物篩 ^ 發現其中有一十六株破囊壺菌科(FamilyThe algal 楂±^ΌΉΑ of Schizochytrium sp., wherein the DHA content of the Schizochytrium Jt product is about 18-22% of the dry algae weight, which has the advantage of being cheap, and the disadvantage is that the DHA content of the product is not easy to obtain; It is about 15-20%, which has the advantage of easily refining high-purity DHA. However, the DHA content is low and it is not easy to culture. Therefore, the mass production cost is high, and at the same time, because of the lack of alcohol, the algae powder of m'ww is recognized. It has a strong pungent smell, so it must be processed by some food processing before it can be sold, causing its cost to soar. ^ Therefore, the development of a high-capacity, easy-to-purify source of DHA will help develop DHA products and provide higher quality D DHA products at a lower price for people to purchase. SUMMARY OF THE INVENTION In view of the lack of prior art, the object of the present invention is to develop a high-yield, easy-to-purify DHA source to reduce the cost and price of DHA products, and to facilitate the promotion of commodities. In view of the above, the present invention provides a medicinal strain for producing DHA, particularly a strain of algae, which has been deposited in the Food Industry Development Research Institute, which is BCRC980009. The invention also includes a use of the algae strain 201033359 for the production of DHA, in particular, the _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ Industrial Development Research Institute 'The algae plant registration number is BCRC98〇〇〇9. The present invention also finds that the algae strain is rich in dha. It can be used for processing human health foods and health medicines, aquatic or animal product additives, and juvenile fish feed. Therefore, the present invention also includes an algal plant product, which is A DHA semi-finished product or purified product obtained by drying or extracting the algae plant described in claim 1 of the patent application. The algae oil obtained by using the algae strain of the invention has the following advantages over the fish oil: high DHA content, stable quality, simple ingredients, easy to further refine into high purity OHA, no heavy metals and polychlorinated biphenyls, etc. Toxic ingredients, vegetarians are edible, and there is no fishy smell. In addition, compared with other algae, the use of the algae strain of the present invention for mass production of similar products has the following advantages: no pungent taste, high DHA content, and the algae strain is native to Taiwan, produced in Taiwan. There are no problems with exotic species. φ [Embodiment] During the development of the present invention, microbial screening was carried out for the coastal areas of Taiwan. ^ There are 16 strains of Thraustochytrium (Family).

Thraustochytriaceae)的單細胞生物具有作為DHA產源的潛 力,這些單細胞生物在標準生長條件進行培養,即在丨升 的血清瓶内置400mL培養基,培養基配方内含三種組成 物^消化蛋白質(peptone)、酵母菌萃取物(yeast extract)、以 及葡萄糖(glucose),含量分別為每升1克、2克及4克。培 養基鹽度為30ppt。培養時接種量為每升〇 〇〇5克,接種後 兩星期採收藻細胞進行分析時,每一升的藻細胞乾重可達 到30〜180mg/L,每克乾藻細胞的脂質含量為15〇〜6〇〇邮, 201033359 且DHA含量佔總脂肪酸含量的1〇%〜58%。 其中,又以如…咕沉紗的·賺屬藻株的DHA含量特別豐 田特別疋Aurantiochytrium mangrovei藤棟,目前業已寄 存於食品工業發展研究所,其寄存編號為BCRC98〇〇〇9。 該藻株在適當條件培養下,其油脂的含量高達73%,其 中40%為DHA。因此可把取得之藻細胞直接乾燥,製成内 含29% DHA的乾粉產品’或把油脂提煉出來,製成内含4〇% DHA的油狀產品,或是進一步的把〇1£4提煉出來,製 ❹ 的DHA產品。 由於本藻株的脂肪酸組成十分單純(第二圖),除了 DHa 外幾乎僅含和DHA的物理性質差異甚大的棕搁酸(分子結 構為16碳飽和酸,C16:0),因此可以利用簡單的製程與^ 櫚酸分離,進而獲得高純度的DHA。 '、’、 本發明發現了 屬藻株富含DHA,因此 本發明也包含將乂屬藻株用於生產富含 DHA之製品的用途。其中前述屬藻株係 為乂 μγ⑽价藻株。目前業已寄存於食品 % 工業發展研究所’寄存編號BCRC980009。 < 口口 目前市面上的藻類產品多採取乾燥或萃取之製程加工 製得,因此本發明也包含一種藻株製品,其係將前述藻株 乾燥或萃取製得。所製得之產品基於製成與用途不同,包 括但不限於乾粉產品、油狀產品或富含DHA產品。 當可輕易理解的是,將本發明之藻株進行加工製得藻株 製品係可採取本技術領域已知的各種加工技術,例如冷 乾燥或各種萃取步驟及器械,具體例示係如美 6,750,048、5,492,938專利號技術’歐盟17〇7〇61專利^技 術等’惟本發明之特徵在於新穎藻株的發現、藻株用途 及該藻株之製品,製得藻株製品的手段係可採取任何已知 201033359 技術而非本發明之關鍵。 以下實施態樣係用於進一步了解本發明之優點,並 於限制本發明之申請專利範圍。 β 實施例:本發明之藻株的培養舆毒性分析 型態特徽 魯在以30ppt鹽度的海水調配,内含消化蛋白質、酵母 出物、葡萄糖、瓊膠各1、2、4、8g/L的固態培養基上進 培養時,本發明之藻株BL10的外觀呈現白色或微黃(第一 圖A)。在細胞群落(colony)成長初期,可觀察到滑動的阿米 巴型細胞(amoeboid cell)(第一圖B,箭頭處)。 、 蒸細胞詈逢 取1升血清瓶,内置lOOmL培養基進行培養,起始培養 基配方為消化蛋白質、酵母菌萃取物及葡萄糖,其含量分 鲁別為每升3克、6克及14〇克,鹽度1〇 ppt。接種藻株為前 述寄存於食品工業發展研究所,寄存編號為BCRC980009 之藻株,接種量為每升0.005 g。培養過程中進行打氣與震 盪(150 rpm)。於接種後3.5天進行葡萄糖的匮料,匱料量為 每升50克。 由此,在接種後第6天的培養密度可達每升59〇g,總 脂肪酸(total fatty acid)及Dha的含量分別達乾藻重的73J;〇 及29彳。利用氣相層析質譜儀,搭配Supelco SP-2380 (81§1^-施也11’1^此,1^0,1;8八)管柱所得到的脂肪酸分 析圖譜如第二圖所示,其中1_6分別為十四碳飽和酸 201033359 (C14:0)、十五碳飽和酸(ci5:〇)、十六碳飽和酸(C16:0)、十 八碳飽和酸(C18:0)、二十二碳五烯酸(C22:5n-6)、以及DHA (C22:6n-3)。 DHA含量比較 如别述篁產方法培養之BL10藻株的生 物重與DHA含量與其他文獻中含有DHA之藻類的比較如 表一所示。 表一,本發明之藻株與其他藻類之DHA含量比較 藻株 生物量(g/L> DHA(g/L) CR* 參考域 Aurantiochytritm BL10 59 16.8 8.4% 本發明 Schizochytrium G13/2S 63 6.1 3.9% Ganuza et αί, 2008 Schizochytrium N-2 13 2.7 3.9% Kamlangdee and Fan, 2003 Schizocf^irium S31 6 0.3 1.3% Wnetal.,2005 Schizochytrium SR21 35 4.2 3.9% Yokochi et αί, 1998 Thraustochytrium ATCC34304 5 0.5 1.9% Bajpd et al., 1991 Thraustochytrium ONC-T18 26 4-5 6.4% Buija et al.7 2006 Crypthecodinium ATCC30772 109 19.0 2.2% Swaaf ei a/., 2002 * CR:培養基一DHA 之轉換率(conversionrate) \The single-celled organism of Thraustochytriaceae has the potential to be a source of DHA. These single-celled organisms are cultured under standard growth conditions, ie 400 mL of medium is contained in a soaring serum bottle containing three components, peptone, The yeast extract and glucose are 1 g, 2 g and 4 g per liter, respectively. The culture base has a salinity of 30 ppt. When inoculated, the inoculation amount is 5 g per liter. When the algae cells are collected two weeks after inoculation, the dry weight of each algae cell can reach 30~180 mg/L, and the lipid content per gram of dry algae cells is 15〇~6〇〇 post, 201033359 and DHA content accounts for 1〇%~58% of total fatty acid content. Among them, the DHA content of the algae strain, such as the 咕 咕 特别 特别 特别 特别 特别 疋 疋 疋 疋 疋 疋 疋 疋 疋 疋 疋 疋 疋 疋 疋 疋 疋 疋 疋 疋 疋 疋 疋 疋 疋 疋 疋 疋 疋 疋 疋 疋 疋 疋 疋 疋 疋 疋 疋 疋 疋 疋The algae strain has a lipid content of up to 73% under appropriate conditions, of which 40% is DHA. Therefore, the obtained algae cells can be directly dried to prepare a dry powder product containing 29% DHA or the oil can be extracted to prepare an oily product containing 4% DHA, or further refined by 〇1£4. Come out and make DHA products. Since the fatty acid composition of this strain is very simple (Fig. 2), except for DHa, it contains almost only palmitic acid (molecular structure of 16 carbon saturated acid, C16:0) which is very different from the physical properties of DHA, so it can be used simply. The process is separated from the palmitic acid to obtain high purity DHA. ',', the present inventors have found that the genus strain is rich in DHA, and therefore the present invention also encompasses the use of the genus Algae to produce a DHA-rich article. The aforementioned strain of the genus is a 乂μγ(10) valerian strain. Currently registered in the Food Industry Development Institute's registration number BCRC980009. < Oral The algae products currently on the market are usually obtained by a drying or extraction process. Therefore, the present invention also encompasses an algal plant product obtained by drying or extracting the above-mentioned algae strain. The products produced are based on manufacture and use, including but not limited to dry powder products, oily products or DHA-rich products. It will be readily understood that the processing of the algal strain of the present invention to produce a strain of algae can be carried out by various processing techniques known in the art, such as cold drying or various extraction steps and apparatus, as exemplified by U.S. 6,750,048, 5,492,938 Patent No. 'European Union 17〇7〇61 Patent^Technology, etc.' However, the present invention is characterized by the discovery of a novel strain of algae, the use of the strain of the algae, and the product of the strain of the algae, and the means for producing the product of the algae may take any Known 201033359 technology is not the key to the invention. The following embodiments are intended to further understand the advantages of the present invention and to limit the scope of the claims of the present invention. Example: Culture of the algae strain of the present invention. The toxicity analysis type of the model is carried out in seawater of 30 ppt salinity, and contains 1, 2, 4, and 8 g of digested protein, yeast extract, glucose, and agar. When the solid medium of L is cultured in above, the appearance of the algal strain BL10 of the present invention is white or yellowish (Fig. A). In the early stages of colony growth, slid-type amoeboid cells (Fig. B, arrows) were observed. The steamed cells are mixed with 1 liter of serum bottle and cultured with 100 mL of medium. The initial medium is formulated as digested protein, yeast extract and glucose, and the content is divided into 3 g, 6 g and 14 g per liter. Salinity is 1 〇ppt. The inoculated algae strain was previously deposited in the Food Industry Development Research Institute, and the algae strain numbered BCRC980009 was inoculated at a rate of 0.005 g per liter. Pumping and oscillating (150 rpm) during the culture. Glucose was digested 3.5 days after inoculation, and the amount of dip was 50 g per liter. Thus, the culture density on the 6th day after inoculation reached 59 〇g per liter, and the total fatty acid and Dha content reached 73 J; 〇 and 29 分别, respectively. The fatty acid analysis profile obtained by gas chromatography mass spectrometry with Supelco SP-2380 (81§1^-Shi also 11'1^,1^0,1;8) pipe column is shown in the second figure. , wherein 1_6 is a fourteen carbon saturated acid 201033359 (C14:0), a fifteen carbon saturated acid (ci5: 〇), a sixteen carbon saturated acid (C16:0), an eighteen carbon saturated acid (C18:0), Docosapentaenoic acid (C22: 5n-6), and DHA (C22: 6n-3). Comparison of DHA content As shown in Table 1, the biomass weight and DHA content of the BL10 strain cultivated by the method of sputum production are compared with the algae containing DHA in other literatures. Table 1 Comparison of DHA content of algae strains and other algae of the present invention (g/L > DHA(g/L) CR* Reference domain Aurantiochytritm BL10 59 16.8 8.4% Schizochytrium G13/2S 63 6.1 3.9% of the present invention Ganuza et αί, 2008 Schizochytrium N-2 13 2.7 3.9% Kamlangdee and Fan, 2003 Schizocf^irium S31 6 0.3 1.3% Wnetal.,2005 Schizochytrium SR21 35 4.2 3.9% Yokochi et αί, 1998 Thraustochytrium ATCC34304 5 0.5 1.9% Bajpd et al 1991, Thraustochytrium ONC-T18 26 4-5 6.4% Buija et al.7 2006 Crypthecodinium ATCC30772 109 19.0 2.2% Swaaf ei a/., 2002 * CR: conversion rate of medium-DHA (conversionrate)

由本表得知,本發明之藻種不僅有較高的DHA產能, 同時有較佳的轉換率(CR),亦即在消耗同重量的培養基 時,所能得到的DHA的量較高,因此量產同重量DHA時 所需的成本較低。 急毒性測試 急毒性測試的方法,是將前述培養所得藻細胞進行冷凍 乾燥後所得到的乾藻粉,以水調勻後灌入SD大鼠的的胃 部。對照組則灌入同體積的水。實驗組及對照組内的公鼠 及母鼠各六隻,其平均體重分別為250g及180g。灌食劑量 8 201033359 為每隻大鼠每公斤8克。灌食後兩星期, 體重降低、腹瀉等異常情況發生。 ,、疋否有死亡、 明顯的 結果顯示,乾藻粉的灌食並未造成任何里常 =劑量’即每隻大鼠每公斤8克對於二鼠並; 练上二斤述,本發明提供—個很好的dha量產 過培養高產能與易純化的藻株來獲得盔 ;式,透 ❿ Ο 且不會引發外來種問題的優良舰;品:士本低、 康、醫藥以及養瘦業方面的需求。此外,以蒸株ίΪ在健 油取代魚油,將崎低人類對於料_捕=之藻 助於維持海洋生態的平衡。 愛力’有 其他實施態樣 在本說明書中所揭露的所有特徵都可能與其 ΐ ’ 斤揭露的每一個特徵都可能選擇性的以: 同、相等或相似目的特徵所取代,因此,除了特別顯 特徵之外’所有的本說明書所揭露的特徵僅是似 特徵中的一個例子。 寻4相似 雖然本發明已以較佳實施例揭露如上,然其並非用以限 定本發明,任何熟悉此技藝者,在不脫離本發明之精神和 範圍内,當可作各種之更動與潤飾。 【圖式簡單說明】 第一圖A係本發明之藤株bli〇的外 觀呈現白、色或微汽。第一圖B則是BL10 的在細胞群落成長初期,可觀察到滑動的阿米巴型細胞(箭 頭處)。 201033359 第二圖係BL10的脂肪酸分析圖譜,其中1-6分別為14 碳飽和酸(C14_.0)、15碳飽和酸(C15:0)、16碳飽和酸 (C16:0)、18 碳飽和酸(C18:0)、22 碳 5 烯酸(C22:5n-6)、以 及 DHA(C22:6n-3)。 201033359 參考文獻It is known from the present table that the algae species of the present invention not only have a higher DHA capacity, but also have a better conversion rate (CR), that is, when the same amount of medium is consumed, the amount of DHA that can be obtained is higher, The cost required for mass production of the same weight DHA is lower. Acute toxicity test The method of the acute toxicity test is to dry the algal powder obtained by freeze-drying the algae cells obtained by the above culture, and mix it with water and then pour it into the stomach of the SD rat. The control group was filled with the same volume of water. Six male and female rats in the experimental group and the control group had an average body weight of 250 g and 180 g, respectively. Feeding dose 8 201033359 is 8 grams per kilogram per rat. Two weeks after the feeding, abnormalities such as weight loss and diarrhea occurred. , or whether there is death, the obvious results show that the feeding of dry algal flour does not cause any regular = dose 'that is, 8 grams per kilogram per rat for two rats; - A good dha mass production of high-capacity and easy-to-purify algae strains to obtain helmets; a type of fine ship that does not cause foreign problems; products: Shiben low, Kang, medicine and thin Industry needs. In addition, the replacement of fish oil with steam oil by steaming plants will help the human race to maintain the balance of marine ecology. All other features disclosed in this specification may be replaced by the same, equal or similar purpose characteristics, so Features other than those described in the specification are merely examples of the features. The present invention has been described above with reference to the preferred embodiments thereof, and is not intended to limit the invention, and various modifications and changes may be made without departing from the spirit and scope of the invention. BRIEF DESCRIPTION OF THE DRAWINGS Fig. 1 is a view showing the appearance of bli〇 of the vine plant of the present invention in white, color or micro-steam. The first panel B shows the sliding amoeba-type cells (arrows) in the early stage of cell population growth of BL10. 201033359 The second figure is the fatty acid analysis of BL10, where 1-6 are 14 carbon saturated acid (C14_.0), 15 carbon saturated acid (C15:0), 16 carbon saturated acid (C16:0), 18 carbon saturated. Acid (C18:0), 22 carbon 5-enoic acid (C22:5n-6), and DHA (C22:6n-3). 201033359 References

Bajpai P. K.5 Bajpai Ρ. and Ward Ο. P.5 199. Optimization of production of docosahexaenoic acid (DHA) by Thraustochytrium aureum ATCC 34304. J. Am. Oil. Chem. Soc., 68: 509-514.Bajpai P. K.5 Bajpai Ρ. and Ward Ο. P.5 199. Optimization of production of docosahexaenoic acid (DHA) by Thraustochytrium aureum ATCC 34304. J. Am. Oil. Chem. Soc., 68: 509-514.

Buija A. M., Radianingtyas H., Windust A. and Barrow C. J., 2006. Isolation and characterization of polyunsaturated fatty acid producing Thraustochytrium species: screening of strains and optimization of omega-3 production. App. Microbiol. Biotechnol., 72: 1161-1169.Buija AM, Radianingtyas H., Windust A. and Barrow CJ, 2006. Isolation and characterization of polyunsaturated fatty acid producing Thraustochytrium species: screening of strains and optimization of omega-3 production. App. Microbiol. Biotechnol., 72: 1161-1169 .

Ganuza E.? Anderson A. J. and Ratledge C., 2008. High-cell-density cultivation of Schizochytrium sp. in an ammonium/pH-auxostat fed-batch system. Biotechnol. Lett. [Epub ahead of print]And the Az.

Kamlangdee N. and Fan K. W·,2003. Polyunsaturated fatty acid production by Schizochytrium sp. isolated from mangrove. Songklanakarin J. Sci. TechnoL, 25: 643-650.Kamlangdee N. and Fan K. W., 2003. Polyunsaturated fatty acid production by Schizochytrium sp. isolated from mangrove. Songklanakarin J. Sci. TechnoL, 25: 643-650.

SwaafM· E. D·,Sijtsma L. and Pronk J. T·,2002· High-cell-density fed-batch cultivation of the docosahexaenoic acid producing marine alga Crypthecodinium cohniL Biotech. Bioeng·,81: 666-672.SwaafM· E. D·, Sijtsma L. and Pronk J. T., 2002· High-cell-density fed-batch cultivation of the docosahexaenoic acid producing marine alga Crypthecodinium cohniL Biotech. Bioeng·, 81: 666-672.

Wu S,T·,Yu S,T· and Lin L·广P.,2005· Effect of culture conditions on docosahexaenoic acid production by Schizochytrium sp. S31. Process Biochem., 40: 3103-3108.Wu S, T·, Yu S, T· and Lin L·广 P., 2005 · Effect of culture conditions on docosahexaenoic acid production by Schizochytrium sp. S31. Process Biochem., 40: 3103-3108.

Yokochi T·,Honda D·,Higashihara T· and Nakahara T·,1998. Optimization of docosahexaenoic acid production by Schizochytrium limacinum SR21. AppL Microbiol. Biotechnol., 49: 72-76.Yokochi T., Honda D., Higashihara T. and Nakahara T., 1998. Optimization of docosahexaenoic acid production by Schizochytrium limacinum SR21. AppL Microbiol. Biotechnol., 49: 72-76.

1111

Claims (1)

201033359 七、申請專利範圍: 1. 一種用於生產富含DHA之製品的屬藻 株0 2. 如申請專利範圍第1項所述之藻株,其係為 Aurantiochytrium mangrovei f条株。 3. 如申請專利範圍第2項所述之藻株,其係為食品工業發 展研究所寄存編號BCRC980009藻株或其衍生簾株。 4· 一種將JwrflwhoctyiWww屬藻株用於生產富含DHA之製 品的用途。201033359 VII. Patent application scope: 1. A strain of algae for producing DHA-rich products. 2. 2. The strain of the plant described in claim 1 is Aurantiochytrium mangrovei f. 3. The strain of algae as described in item 2 of the patent application is deposited by the Food Industry Development Research Institute under the accession number BCRC980009 or its derived curtain. 4. A use of a Jwrflwhoctyi Www strain of algae for the production of a DHA-rich product. 5.如申請專利範圍第4項所述之用途,其中前述 Au聰ti〇chytrium 屬蒸株係為 Auranti〇chyMumma叩謂ei 蒸株。 6. 如申請專利範圍第5項所述之用途,其中前述 如咖‘〇咖的·謂敗藻株係為食品工業發展研究 所寄存編號BCRC980009之藻株或其衍生藻株。 7. —種藻株製品,其係將如申請專利範 株乾燥或萃取製得。 乾圍第1項所返之邊 8. 如申請專利範圍帛i項所述之藻株 品、油狀產品或富含DHA產品。 -係為乾叔產 9. 如申請專利範圍第1項所述之藻株 半純化DHA產品。 απ,,、係為純化或 125. The use according to claim 4, wherein the aforementioned Au Cong ti〇chytrium genus is Auranti 〇 M Mumma 叩 ei steamed. 6. The use according to item 5 of the patent application, wherein the aforementioned "Acacia" is a strain of algae or a derivative thereof of the number BCRC980009 registered by the Food Industry Development Research Institute. 7. An algae plant product which will be prepared by drying or extracting the patented patent. The back of the first paragraph of the dry circumference 8. If the application is in the scope of the patent range 帛i, the algae product, the oily product or the DHA-rich product. - The system is dry and unproductive 9. The semi-purified DHA product of the algae plant as described in claim 1 of the patent application. Ππ,,, is purified or 12
TW098107877A 2009-03-11 2009-03-11 Alga strain rich in dha and application of the same TWI372181B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW098107877A TWI372181B (en) 2009-03-11 2009-03-11 Alga strain rich in dha and application of the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW098107877A TWI372181B (en) 2009-03-11 2009-03-11 Alga strain rich in dha and application of the same

Publications (2)

Publication Number Publication Date
TW201033359A true TW201033359A (en) 2010-09-16
TWI372181B TWI372181B (en) 2012-09-11

Family

ID=44855126

Family Applications (1)

Application Number Title Priority Date Filing Date
TW098107877A TWI372181B (en) 2009-03-11 2009-03-11 Alga strain rich in dha and application of the same

Country Status (1)

Country Link
TW (1) TWI372181B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI468114B (en) * 2010-10-13 2015-01-11 Taiam Pan Algasis Inc Alga edible oil production method

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI552683B (en) * 2013-12-25 2016-10-11 國立成功大學 Use of dha-producing microalgae in aquaculture
TWI713960B (en) * 2018-12-22 2020-12-21 國立成功大學 Method for lowering cannibalism rate in fish

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI468114B (en) * 2010-10-13 2015-01-11 Taiam Pan Algasis Inc Alga edible oil production method

Also Published As

Publication number Publication date
TWI372181B (en) 2012-09-11

Similar Documents

Publication Publication Date Title
US8232090B2 (en) Strain of Schizochytrium limacinum useful in the production of lipids and extracellular polysaccharides and process thereof
JP3985035B2 (en) (N-6) Docosapentaenoic Acid-Containing Oil and Fat, Method for Producing the Oil and Use, and Use
CA2675691C (en) Methods for producing polyunsaturated fatty acid and lipid containing polyunsaturated fatty acid
TWI352122B (en) A crude oil, a refined oil, and a general food and
JP2020072676A (en) Eicosapentaenoic acid-producing microorganisms, fatty acid compositions, and methods of making and uses thereof
US6958229B2 (en) Method for producing highly unsaturated fatty acids and lipid containing same
Colonia et al. Omega-3 microbial oils from marine thraustochytrids as a sustainable and technological solution: a review and patent landscape
JP2006345866A (en) Method for forming arachidonic acid
WO1996033263A1 (en) Novel microorganisms capable of producing highly unsaturated fatty acids and process for producing highly unsaturated fatty acids by using the microorganisms
CA2792494C (en) Yeast strains and their uses in the production of lipids
HU229062B1 (en) Process for preparing docosahexaenoic acid and docosapentaenoic acid
JP2004215668A (en) Docosahexaenoic acid and compound containing docosahexaenoic acid
CN105410925A (en) Fatty acid compositions
JP6888035B2 (en) Production of omega-3 fatty acids from phytium species
TW201033359A (en) Alga strain rich in DHA and application of the same
JP2022002522A (en) High density production of biomass and oil using crude glycerol
JPWO2009038029A1 (en) Method for producing ω3 series highly unsaturated fatty acid
CN104988078B (en) Thraustochytrid, fatty acid composition and preparation method and application thereof
JP4047354B2 (en) Novel Labyrinthula microorganism with high productivity of docosahexaenoic acid (DHA) and use thereof
JP4047354B6 (en) Novel Labyrinthula microorganism with high productivity of docosahexaenoic acid (DHA) and use thereof
US20230235371A1 (en) Method for culturing microorganisms for lipid accumulation
Bhosale et al. Freshwater algae as potential source of polyunsaturated fatty acids
CN107109378A (en) The manufacture method of new omega-3 fatty acid desaturase and eicosapentaenoic acid
KR20010010268A (en) Arachidonic Acid Reinforced Feed Composition